Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1426 AL 1440

MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial

Clark DO, Xu H, Moser L, Adeoye P, Lin AW, Tangney CC, Risacher SL, Saykin AJ, Considine RV, Unverzagt FW.

Contemp Clin Trials. 2019 Sep;84:105814. doi: 10.1016/j.cct.2019.105814. Epub 2019 Jul 18.

Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study

Morrill SJ, Gibas KJ.

Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1187-1191. doi: 10.1016/j.dsx.2019.01.035. Epub 2019 Jan 24.

The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers

Tang KS.

Life Sci. 2019 Sep 15;233:116695. doi: 10.1016/j.lfs.2019.116695. Epub 2019 Jul 25.

Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease

Archetti D, Ingala S, Venkatraghavan V, Wottschel V, Young AL, Bellio M, Bron EE, Klein S, Barkhof F, Alexander DC, Oxtoby NP, Frisoni GB, Redolfi A; Alzheimer's Disease Neuroimaging Initiative; for EuroPOND Consortium.

Neuroimage Clin. 2019;24:101954. doi: 10.1016/j.nicl.2019.101954. Epub 2019 Jul 23.

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers

Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn C, Saykin AJ, Kaddurah-Daouk R; Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.

Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study

Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, Incesoy E, Priller J, Spruth E, Altenstein S, Buerger K, Catak C, Janowitz D, Perneczky R, Utecht J, Laske C, Buchmann M, Schneider A, Fliessbach K, Kalbhen P, Heneka MT, Brosseron F, Spottke A, Roy N, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Düzel E, Dobisch L, Metzger C, Meiberth D, Ramirez A, Jessen F, Wagner M.

Alzheimers Res Ther. 2019 Jul 31;11(1):66. doi: 10.1186/s13195-019-0515-y.

Blood circulating miRNAs as biomarkers of Alzheimer's disease: a systematic review and meta-analysis

Zhang YH, Bai SF, Yan JQ.

Biomark Med. 2019 Aug;13(12):1045-1054. doi: 10.2217/bmm-2018-0341. Epub 2019 Aug 6.

Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review

Petersen ME, O'Bryant SE.

Dev Neurobiol. 2019 Jul;79(7):699-710. doi: 10.1002/dneu.22714. Epub 2019 Sep 3.

Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview

Matej R, Tesar A, Rusina R.

Clin Biochem. 2019 Nov;73:26-31. doi: 10.1016/j.clinbiochem.2019.08.005. Epub 2019 Aug 7.

[New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood]

Vogelgsang J, Wiltfang J.

Nervenarzt. 2019 Sep;90(9):907-913. doi: 10.1007/s00115-019-0772-9.

Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid

Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J, Zhou C, Liang F, Shi S, Wang S, Qin W, Wang Q, Li F, Wang Q, Li Y, Shen L, Wei Y, Jia J.

Alzheimers Dement. 2019 Aug;15(8):1071-1080. doi: 10.1016/j.jalz.2019.05.002.

Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer's Dementia (EPAD) V500.0 Cohort

Stirland LE, Russ TC, Ritchie CW, Muniz-Terrera G; EPAD Consortium.

J Alzheimers Dis. 2019;71(2):703-711. doi: 10.3233/JAD-190222.

Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review

Showraki A, Murari G, Ismail Z, Barfett JJ, Fornazzari L, Munoz DG, Schweizer TA, Fischer CE.

J Alzheimers Dis. 2019;71(2):477-501. doi: 10.3233/JAD-190365.

Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME.

PLoS One. 2019 Aug 20;14(8):e0221365. doi: 10.1371/journal.pone.0221365. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias